A new AI start­up, launched with a trio of Fred Hutch vets, wants to give a 'zoomed-in' view of can­cer cells

Ali Ansary, a trained physi­cian, had re­al­ized by 2018 that can­cers would no longer be treat­ed just with tra­di­tion­al chemother­a­py and ra­di­a­tions. Im­munother­a­py was be­com­ing big, and yet there was no way for doc­tors to get a com­plete pic­ture of how im­mune cells worked at the cel­lu­lar lev­el when used for can­cer ther­a­py, he says.

“How do we get to know more in­for­ma­tion about this sys­tem that is more than in­flam­ma­to­ry mark­ers?” he won­dered.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER